Infirst Later Than Expected With Lipid-Format Ibuprofen, But On Time In Business Plan
This article was originally published in The Tan Sheet
Executive Summary
The London firm announces Unicough cough/cold product’s launch after reviewing clinical trial results, but holds off on a Flarin ibuprofen launch until completing a trial. “We’re very, very pleased with this, although originally we wanted to be there slightly earlier,” says CEO Manfred Scheske.